Olmesartan Benicar info

A friend writes:

So, I have three prescription drugs: two to lower my blood pressure, the other a potassium supplement needed because the two blood pressure medications leach potassium from my body — is this a great country, or what?!

My pharmacy is my nearest grocery store.

I changed my prescription drug plan effective 2021.

Last week, online, I filled out a prescription refill order for the three medications.

Today, I went online to see if they are ready to be picked up. They are.

The charge for the 90-day supply of the potassium pills, potassium chloride extended release 10 meq tablet, was the usual $6.

The charge for the 90-day supply of one of my blood-pressure medications, amlodipine besylate 10 mg tablet (brand name would be Norvasc), was the usual $0.00.

But the charge for the second blood-pressure medication, olmesartan-HCTZ 40-25 mg tablet (brand name would be Benicar HCT), was … $771.99.


Before calling the prescription drug plan to say “Hey?,” I called the grocery store’s pharmacy and explained why I was calling, ending with: “Is that a … mistake?” Without missing a beat, the young pharmacist on the phone said, “Yes, that was a mistake. It’s supposed to be a charge of $6.” (Note: That drug used to be no charge and now is $6. But whatever.)

I asked the young lady how the error could have happened, and she said: “It was put through as a cash payment rather than sent through your insurance” — note: unlike the other two medication refill requests that were submitted at exactly the same time — “I’m very sorry. That must have been quite a shock.”

Errr … yes. Quite a shock. But then again, not really. Because this is the state of health care in ‘mer’ca.

Now, please excuse me while I go to the pharmacy to pick up my medication to lower my blood pressure, which has suddenly spiked.

Jeanne Pinder

Jeanne Pinder  is the founder and CEO of ClearHealthCosts. She worked at The New York Times for almost 25 years as a reporter, editor and human resources executive, then volunteered for a buyout and founded...